Archive: 30/09/2014
Correction of cardiovascular symptoms of MPS I in animal model
REGENXBIO Inc. today announced that gene transfer mediated by REGENXBIO's NAV AAV8 vectors resulted in sustained serum α-L-iduronidase (IDUA) expression, as well as correction of systemic features of MPS I, or Hurler syndrome, ...
Sep 30, 2014
High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes
Administration of high-dose vitamin D3 compared with placebo did not reduce hospital length of stay, intensive care unit (ICU) length of stay, hospital mortality, or the risk of death at 6 months among patients with vitamin ...
Sep 30, 2014